作者投稿
专家审稿
编辑办公
邮件订阅
RSS
Progress and Application of Medical Informatics in the Diagnosis and Treatment of Rare Diseases
-
摘要: 罕见病种类繁多、表型复杂，存在遗传异质性和临床异质性，故其诊断极具挑战，且治疗方面缺乏有效药物。随着临床语义系统研究、二代测序、影像组学数据分析、多组学融合分析等医学信息学技术研究的不断深入，罕见病在数据共享、科学研究等方面的限制正在逐步被打破。整合和研究不同来源的罕见病相关共享数据，有利于更多致病位点的发现和孤儿药的开发，可促进罕见病的诊断和治疗。本文旨在介绍医学信息学技术在罕见病领域的研究进展及应用, 以期推动医学信息学在罕见病诊疗方面的发展。Abstract: Rare diseases have a wide variety, complicated manifestations, and genetic and clinical heterogeneity, which make the diagnosis highly challenging.Moreover, many of the diseases lack effective therapies.The research in medical informatics technologies, such as clinical semantic system, genomic data analysis, imaging data analysis, and multi-omics data fusion analysis, has been greatly improved with the development of precision medical informatics, which is gradually breaking the restrictions of rare disease in data sharing and scientific research of rare diseases. Integrating and studying the shared data of rare diseases from different sources is conducive to the discovery of more pathogenic loci and the development of orphan drugs, which will promote the diagnosis and treatment of rare diseases. This review aims to introduce recent research progresses and applications of medical informatics technologies on rare diseases, in order to promote the development of medical informatics in the diagnosis and treatment of rare disease.
-
Key words:
- rare diseases /
- medical information /
- terminology standard /
- genomics /
- phenome-wide association studies
-
[1] Fung KW, Richesson R, Bodenreider O. Coverage of rare disease names in standard terminologies and implications for patients, providers, and research [J]. AMIA Annu Symp Proc, 2014: 564-572. http://www.ncbi.nlm.nih.gov/pubmed/25954361?dopt [2] Boycott KM, Dyment DA, Sawyer SL, et al. Identification of genes for childhood heritable diseases [J]. Annu Rev Med, 2014, 65: 19-31. doi: 10.1146/annurev-med-101712-122108 [3] Schieppati A, Henter JI, Daina E, et al. Why rare diseases are an important medical and social issue [J]. Lancet, 2008, 371: 2039-2041. doi: 10.1016/S0140-6736(08)60872-7 [4] Boycott KM, Rath A, Chong JX, et al. International cooperation to enable the diagnosis of all rare genetic diseases [J]. Am J Hum Genet, 2017, 100: 695-705. doi: 10.1016/j.ajhg.2017.04.003 [5] Liang J, Wei K, Meng Q, et al. Development of medical informatics in China over the past 30 years from a conference perspective and a Sino-American comparison [J]. Peer J, 2017, 5: e4082. [6] Roos M, López Martin E, Wilkinson MD. Preparing data at the source to foster interoperability across rare disease resources [J]. Adv Exp Med Biol, 2017, 1031: 165-179. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=9bcbb0af08c4b5d2a45f67db0ca063df [7] Ma'ayan A, Rouillard AD, Clark NR, et al. Lean big data integration in systems biology and systems pharmacology [J]. Trends Pharmacol Sci, 2014, 35: 450-460. doi: 10.1016/j.tips.2014.07.001 [8] He Z, Chen Y, de Coronado S, et al. Topological-pattern-based recommendation of UMLS concepts for national cancer institute thesaurus [J]. AMIA Annu Symp Proc, 2016: 618-627. http://europepmc.org/abstract/MED/28269858 [9] Köhler S, Vasilevsky NA, Engelstad M, et al. The human phenotype ontology in 2017 [J]. Nucleic Acids Res, 2017, 45: D865-D876. http://www.ncbi.nlm.nih.gov/pubmed/27899602 [10] Köhler S, Doelken SC, Mungall CJ, et al. The human phenotype ontology project: linking molecular biology and disease through phenotype data [J]. Nucleic Acids Res, 2014, 42: D966-D974. doi: 10.1093/nar/gkt1026 [11] Greene D, BioResource N, Richardson S, et al. Phenotype similarity regression for identifying the genetic determinants of rare diseases [J]. Am J Hum Genet, 2016, 98: 490-499. doi: 10.1016/j.ajhg.2016.01.008 [12] Sarntivijai S, Vasant D, Jupp S, et al. Linking rare and common disease: mapping clinical disease-phenotypes to ontologies in therapeutic target validation [J]. J Biomed Semantics, 2016, 7: 8. doi: 10.1186/s13326-016-0051-7 [13] Velupillai S, Mowery D, South BR, et al. Recent advances in clinical natural language processing in support of semantic analysis [J]. Yearb Med Inform, 2015, 10: 183-193. http://old.med.wanfangdata.com.cn/viewHTMLEn/PeriodicalPaper_PM26293867.aspx [14] Machado CM, Rebholz-Schuhmann D, Freitas AT, et al. The semantic web in translational medicine: current applications and future directions [J]. Brief Bioinform, 2015, 16: 89-103. doi: 10.1093/bib/bbt079 [15] De Silva TS, MacDonald D, Paterson G, et al. Systematized nomenclature of medicine clinical terms (SNOMED CT) to represent computed tomography procedures [J]. Comput Methods Programs Biomed, 2011, 101: 324-329. doi: 10.1016/j.cmpb.2011.01.002 [16] Lambin P, Leijeaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine [J]. Nat Rev Clin Oncol, 2017, 14: 749-762. doi: 10.1038/nrclinonc.2017.141 [17] Polan DF, Brady SL, Kaufman RA.Tissue segmentation of computed tomography images using a random forest algorithm: a feasibility study [J]. Phys Med Biol, 2016, 61: 6553-6569. doi: 10.1088/0031-9155/61/17/6553 [18] Zhang L, Fried DV, Fave XJ, et al. IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics [J]. Med Phys, 2015, 42: 1341-1353. doi: 10.1118/1.4908210 [19] Parmar C, Grossmann P, Bussink J, et al. Machine learning methods for quantitative radiomic biomarkers [J]. Sci Rep, 2015, 5: 13087. doi: 10.1038/srep13087 [20] Liehr T, Acquarola N, Pyle K, et al. Next generation phenotyping in emanuel and pallister-killian syndrome using computer-aided facial dysmorphology analysis of 2D photos [J]. Clin Genet, 2018, 93:378-381. doi: 10.1111/cge.13087 [21] Katsanis SH, Katsanis N. Molecular genetic testing and the future of clinical genomics [J]. Nat Rev Genet, 2013, 14: 415-426. http://www.ncbi.nlm.nih.gov/pubmed/23681062/ [22] Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for mendelian disease gene discovery [J]. Nat Rev Genet, 2011, 12: 745-755. doi: 10.1038/nrg3031 [23] Fernandez-Marmiesse A, Gouveia S, Couce ML. NGS technologies as a turning point in rare disease research, diagno-sis, and treatment [J]. Curr Med Chem, 2018, 25:404-432. doi: 10.2174/0929867324666170718101946 [24] Gligorijevi c V, Malod-Dognin N, Pr z ulj N. Integrative meth-ods for analyzing big data in precision medicine [J]. Proteomics, 2016, 16: 741-758. doi: 10.1002/pmic.201500396 [25] Visscher PM, Brown MA, McCarthy MI, et al. Five years of GWAS discovery [J]. Am J Hum Genet, 2012, 90: 7-24. doi: 10.1016/j.ajhg.2011.11.029 [26] Denny JC, Bastarache L, Roden DM. Phenome-wide association studies as a tool to advance precision medicine [J]. Annu Rev Genomics Hum Genet, 2016, 17: 353-373. doi: 10.1146/annurev-genom-090314-024956 [27] Visscher PM, Wray NR, Zhang Q, et al. 10 Years of GWAS discovery: biology, function, and translation [J]. Am J Hum Genet, 2017, 101: 5-22. doi: 10.1016/j.ajhg.2017.06.005 [28] Denny JC, Ritchie MD, Basford MA, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations [J]. Bioinformatics, 2010, 26: 1205-1210. doi: 10.1093/bioinformatics/btq126 [29] Bush WS, Oetjens MT, Crawford DC.Unravelling the human genome-phenome relationship using phenome-wide association studies [J]. Nat Rev Genet, 2016, 17: 129-145. doi: 10.1038/nrg.2015.36 [30] McKusick VA. Mendelian Inheritance in Man and its online version, OMIM [J]. Am J Hum Genet, 2007, 80: 588-604. doi: 10.1086/514346 [31] Pavan S, Rommel K, Mateo Marquina ME, et al. Clinical practice guidelines for rare diseases: the orphanet database [J]. PLoS One, 2017, 12: e0170365. http://pubmedcentralcanada.ca/pmcc/articles/PMC5242437/ [32] Swaminathan GJ, Bragin E, Chatzimichali EA, et al. DECIPHER: web-based, community resource for clinical interpretation of rare variants in developmental disorders [J]. Hum Mol Genet, 2012, 21: R37-R44. http://europepmc.org/articles/PMC3459644 [33] Zhang X, Minikel EV, O'Donnell-Luria AH, et al. ClinVar data parsing [J]. Wellcome Open Res, 2017, 2: 33. doi: 10.12688/wellcomeopenres.11640.1 [34] Stenson PD, Ball EV, Mort M, et al. The human gene mutation database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution [J]. Curr Protoc Bioinformatics,2012,Chapter 1:Unit1.13. [35] Stelzer G, Rosen N, Plaschkes I, et al. The gene cards suite: from gene data mining to disease genome sequence analyses [J]. Curr Protoc Bioinformatics, 2016, 54:1.30.1-1.30.33. doi: 10.1002/cpbi.5/pdf [36] Rappaport N, Twik M, Plaschkes I, et al. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search [J]. Nucleic Acids Res, 2017, 45: D877-D887. http://pubmedcentralcanada.ca/pmcc/articles/PMC5210521/figure/F3/ [37] Pepin MG, Murray ML, Bailey S, et al. The challenge of comprehensive and consistent sequence variant interpretation between clinical laboratories [J]. Genet Med, 2016, 18: 20-24. doi: 10.1038/gim.2015.31 [38] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology [J]. Genet Med, 2015, 17: 405-424. doi: 10.1038/gim.2015.30 [39] Van Dijk EL, Auger H, Jaszczyszyn Y, et al. Ten years of next-generation sequencing technology [J]. Trends Genet, 2014, 30: 418-426. doi: 10.1016/j.tig.2014.07.001 [40] Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder [J]. Nat Genet, 2010, 42: 30-35. doi: 10.1038/ng.499 [41] Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome [J]. Nat Genet, 2010, 42: 790-793. doi: 10.1038/ng.646 [42] Hoischen A, van Bon BW, Gilissen C, et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome [J]. Nat Genet, 2010, 42: 483-485. doi: 10.1038/ng.581 [43] Gilissen C, Arts HH, Hoischen A, et al. Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome [J]. Am J Hum Genet, 2010, 87: 418-423. doi: 10.1016/j.ajhg.2010.08.004 [44] Beaulieu CL, Majewski J, Schwartzentruber, et al. FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project [J]. Am J Hum Genet, 2014, 94: 809-817. doi: 10.1016/j.ajhg.2014.05.003 [45] Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations [J]. Nucleic Acids Res, 2014, 42: D1001-D1006. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=HighWire000006278284 [46] Duan L, Wei L, Tian Y, et al. Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study [J]. Stroke, 2018, 49: 11-18. doi: 10.1161/STROKEAHA.117.017430 [47] Sardana D, Zhu C, Zhang M, et al.Drugrepositioningforor-phandiseases[J]. Brief Bioinform, 2011, 12: 346-356. doi: 10.1093/bib/bbr021 [48] Stockklausner C, Lampert A, Hoffmann GF, et al. Novel treatments for rare cancers: the U.S. orphan drug act is deli-vering-A cross-sectional analysis [J]. Oncologist, 2016, 21: 487-493. doi: 10.1634/theoncologist.2015-0397 [49] Zhao M, Wei DQ. Rare diseases: drug discovery and informatics resource [J]. Interdiscip Sci, 2018, 10:195-204. doi: 10.1007/s12539-017-0270-3 [50] Kodra Y, Posada de la Paz M, Coi A, et al. Data quality in rare diseases registries [J]. Adv Exp Med Biol, 2017, 1031: 149-164. http://www.ncbi.nlm.nih.gov/pubmed/29214570 -
下载:
点击查看大图
图(1)
计量
- 文章访问数: 265
- HTML全文浏览量: 48
- PDF下载量: 432
- 被引次数: 0
